Related Experiment Video

Updated: May 13, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

[Vesicular stomatitis virus in the fight against cancer]

Valérie Janelle1, Laurent Poliquin, Alain Lamarre

  • 1Laboratoire d'immunovirologie, Institut national de la recherche scientifique, Laval, Québec, Canada. valerie.janelle@iaf.inrs.ca

Medecine Sciences : M/S
|March 5, 2013
PubMed

Insights

Oncolytic virotherapy uses viruses like vesicular stomatitis virus (VSV) to target cancer cells. Combining different viruses may improve treatment efficacy against diverse and evasive tumors.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Context:

  • Cancer is a leading global health challenge with limitations in current treatments.
  • Oncolytic virotherapy presents a promising alternative by utilizing viruses to selectively destroy cancer cells.
  • Vesicular stomatitis virus (VSV) shows potential due to its ability to infect many human tumor cells.

Purpose:

  • To explore the potential of oncolytic viruses, specifically VSV, in cancer treatment.
  • To highlight the need for therapeutic combinations due to tumor heterogeneity and immune evasion.
  • To emphasize the importance of understanding viral infection mechanisms and immune responses.

Summary:

  • Vesicular stomatitis virus (VSV) is being investigated for oncolytic virotherapy due to its tumor cell infectivity.
  • Tumor cell diversity and evasion strategies necessitate the use of multiple oncolytic viruses for effective cancer treatment.
  • Further research into oncolytic virus mechanisms and immunomodulation is crucial for developing safe and effective therapies.

Impact:

  • Advances in oncolytic virotherapy could lead to more effective and targeted cancer treatments.
  • Understanding viral-cancer interactions may pave the way for novel therapeutic strategies.
  • Improved treatment outcomes for cancer patients through innovative virotherapy approaches.

More Related Videos

Ex Vivo Infection of Live Tissue with Oncolytic Viruses12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...